These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 18958573

  • 1. Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study.
    Nobili F, Frisoni GB, Portet F, Verhey F, Rodriguez G, Caroli A, Touchon J, Calvini P, Morbelli S, De Carli F, Guerra UP, Van de Pol LA, Visser PJ.
    J Neurol; 2008 Sep; 255(9):1344-53. PubMed ID: 18958573
    [Abstract] [Full Text] [Related]

  • 2. SPECT predictors of cognitive decline and Alzheimer's disease in mild cognitive impairment.
    Nobili F, De Carli F, Frisoni GB, Portet F, Verhey F, Rodriguez G, Caroli A, Touchon J, Morbelli S, Guerra UP, Dessi B, Brugnolo A, Visser PJ.
    J Alzheimers Dis; 2009 Sep; 17(4):761-72. PubMed ID: 19542623
    [Abstract] [Full Text] [Related]

  • 3. Significant correlation between cerebral hypoperfusion and neuropsychological assessment scores of patients with mild cognitive impairment.
    Yoon HJ, Park KW, Jeong YJ, Kang DY.
    Nucl Med Commun; 2012 Aug; 33(8):848-58. PubMed ID: 22692580
    [Abstract] [Full Text] [Related]

  • 4. Amnestic mild cognitive impairment in Parkinson's disease: a brain perfusion SPECT study.
    Nobili F, Abbruzzese G, Morbelli S, Marchese R, Girtler N, Dessi B, Brugnolo A, Canepa C, Drosos GC, Sambuceti G, Rodriguez G.
    Mov Disord; 2009 Feb 15; 24(3):414-21. PubMed ID: 19235928
    [Abstract] [Full Text] [Related]

  • 5. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ, Gorno-Tempini ML, Schuff N.
    Radiology; 2005 Mar 15; 234(3):851-9. PubMed ID: 15734937
    [Abstract] [Full Text] [Related]

  • 6. Brain perfusion SPECT in patients with mild cognitive impairment and Alzheimer's disease: comparison of a semiquantitative and a visual evaluation.
    Staffen W, Schönauer U, Zauner H, Spindler I, Mair A, Iglseder B, Bernroider G, Ladurner G.
    J Neural Transm (Vienna); 2006 Feb 15; 113(2):195-203. PubMed ID: 15959843
    [Abstract] [Full Text] [Related]

  • 7. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F, Brugnolo A, Calvini P, Copello F, De Leo C, Girtler N, Morbelli S, Piccardo A, Vitali P, Rodriguez G.
    Clin Neurophysiol; 2005 Feb 15; 116(2):364-75. PubMed ID: 15661114
    [Abstract] [Full Text] [Related]

  • 8. Unawareness of memory deficit in amnestic MCI: FDG-PET findings.
    Nobili F, Mazzei D, Dessi B, Morbelli S, Brugnolo A, Barbieri P, Girtler N, Sambuceti G, Rodriguez G, Pagani M.
    J Alzheimers Dis; 2010 Feb 15; 22(3):993-1003. PubMed ID: 20858977
    [Abstract] [Full Text] [Related]

  • 9. Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment.
    Tranfaglia C, Palumbo B, Siepi D, Sinzinger H, Parnetti L.
    Hell J Nucl Med; 2009 Feb 15; 12(2):110-4. PubMed ID: 19675861
    [Abstract] [Full Text] [Related]

  • 10. Temporal lobe hypoperfusion in isolated amnesia with slow onset: a single photon emission computer tomography study.
    Høgh P, Madsen Sjö N, Gade A, Waldemar G.
    Dement Geriatr Cogn Disord; 2004 Feb 15; 18(1):15-23. PubMed ID: 15084789
    [Abstract] [Full Text] [Related]

  • 11. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.
    Habert MO, Horn JF, Sarazin M, Lotterie JA, Puel M, Onen F, Zanca M, Portet F, Touchon J, Verny M, Mahieux F, Giron A, Fertil B, Dubois B.
    Neurobiol Aging; 2011 Jan 15; 32(1):15-23. PubMed ID: 19250707
    [Abstract] [Full Text] [Related]

  • 12. Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.
    Encinas M, De Juan R, Marcos A, Gil P, Barabash A, Fernández C, De Ugarte C, Cabranes JA.
    Eur J Nucl Med Mol Imaging; 2003 Nov 15; 30(11):1473-80. PubMed ID: 14579086
    [Abstract] [Full Text] [Related]

  • 13. Brain perfusion abnormalities in Alzheimer's disease: comparison between patients with focal temporal lobe dysfunction and patients with diffuse cognitive impairment.
    Cappa A, Calcagni ML, Villa G, Giordano A, Marra C, De Rossi G, Puopolo M, Gainotti G.
    J Neurol Neurosurg Psychiatry; 2001 Jan 15; 70(1):22-7. PubMed ID: 11118243
    [Abstract] [Full Text] [Related]

  • 14. Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment.
    Bokde AL, Lopez-Bayo P, Meindl T, Pechler S, Born C, Faltraco F, Teipel SJ, Möller HJ, Hampel H.
    Brain; 2006 May 15; 129(Pt 5):1113-24. PubMed ID: 16520329
    [Abstract] [Full Text] [Related]

  • 15. Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment.
    Caroli A, Testa C, Geroldi C, Nobili F, Barnden LR, Guerra UP, Bonetti M, Frisoni GB.
    J Neurol; 2007 Dec 15; 254(12):1698-707. PubMed ID: 17990057
    [Abstract] [Full Text] [Related]

  • 16. (99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease.
    Devanand DP, Van Heertum RL, Kegeles LS, Liu X, Jin ZH, Pradhaban G, Rusinek H, Pratap M, Pelton GH, Prohovnik I, Stern Y, Mann JJ, Parsey R.
    Am J Geriatr Psychiatry; 2010 Nov 15; 18(11):959-72. PubMed ID: 20808143
    [Abstract] [Full Text] [Related]

  • 17. Visual attention deficits in Alzheimer's disease: relationship to HMPAO SPECT cortical hypoperfusion.
    Vasquez BP, Buck BH, Black SE, Leibovitch FS, Lobaugh NJ, Caldwell CB, Behrmann M.
    Neuropsychologia; 2011 Jun 15; 49(7):1741-50. PubMed ID: 21377483
    [Abstract] [Full Text] [Related]

  • 18. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I, Quirce R, Martínez-Rodríguez I, Jiménez-Bonilla J, Portilla-Quattrociocchi H, Medina-Quiroz P, Ortega F, Rodríguez E, Mateo I, Vázquez-Higuera JL, de Arcocha M, Carril JM.
    Rev Esp Med Nucl; 2011 Jun 15; 30(5):301-6. PubMed ID: 21640440
    [Abstract] [Full Text] [Related]

  • 19. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.
    Coutinho AM, Porto FH, Duran FL, Prando S, Ono CR, Feitosa EA, Spíndola L, de Oliveira MO, do Vale PH, Gomes HR, Nitrini R, Brucki SM, Buchpiguel CA.
    Alzheimers Res Ther; 2015 Sep 15; 7(1):58. PubMed ID: 26373380
    [Abstract] [Full Text] [Related]

  • 20. Correlation between neuropsychological tests and hypoperfusion in MCI patients: anatomical labeling using xjView and Talairach Daemon software.
    Yoon HJ, Park KW, Jeong YJ, Kang DY.
    Ann Nucl Med; 2012 Oct 15; 26(8):656-64. PubMed ID: 22777857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.